Biological
CSL112
CSL112 is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
2
50%
Ph phase_2
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
NCT02108262
completedphase_2
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
NCT02742103
completedphase_1
A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment
NCT02427035
completedphase_1
A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers
NCT01281774
Clinical Trials (4)
Showing 4 of 4 trials
NCT02108262Phase 2
A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
NCT02742103Phase 2
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
NCT02427035Phase 1
A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment
NCT01281774Phase 1
A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4